Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
Clinical trial NCT00976820 · COMPLETED
Trial details
- NCT number
- NCT00976820
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-20
- Primary completion
- 2011-03-21
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.